Evolution of tumour biology upon progression.: Do we know our enemy?
págs. 399-400
Merkel cell carcinoma:: What do we know about it and what should we do?
Isabel Prieto Muñoz, José Pardo Masferrer, Jesús Olivera Vegas, José Fortés Alen, Ana María Pérez Casas
págs. 401-412
Chemotherapy-induced nausea and vomiting:: pathophysiology and therapeutic principles
Juan Bayo Calero, P. Jiménez Fonseca, Susana Hernando Polo, Sònia Servitja Tormo, Aitana Calvo Ferrándiz, Sandra Falagán Martínez, Estefanía García Pérez, Iria González Maeso, María José de Miguel Peláez, Quionia Pérez Arnillas, Ana Milena Roldan, Antonio Ruiz Fernández, Agustí Barnadas i Molins
págs. 413-422
Functions and workload of medical oncologists in Spain
Cristina Grávalos Castro, Javier Salvador Bofill, Joan Albanell Mestres, Agustí Barnadas i Molins, Pablo Borrega García, Jesús García Mata, Pilar Garrido López, E. González Flores, Dolores Isla Casado, María Lomas Garrido, Álvaro Rodríguez Lescure, Juan Jesús Cruz Hernández, Emilio Alba
págs. 423-429
Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients:: results from the GEICAM/2002-01 phase II study
Pedro Sánchez Rovira, A. Antón Torres, Agustí Barnadas i Molins, Amalia Velasco, María Lomas Garrido, María Rodríguez-Pinilla, José Luis Ramírez, César Ramírez, María José Ríos, Eva Castellà Fernández, Carmen García-Andrade, Belén San Antonio, Eva Carrasco, José Luis Palacios
págs. 430-436
págs. 437-443
Expanding Sca-1+ mammary stem cell in the presence of oestrogen and growth hormone
Xiaowei Dou, Bin Zhang, Rui Liu, Jing Li, Dan Shi, Chunhua Lu, Xishan Zhu, Lianming Liao, Zhijian Du, Robert Chunhua Zhao
págs. 444-451
Biological markers of cisplatin resistance in advanced testicular germ cell tumours
Adelaida García Velasco, Ignacio Durán Martínez, Elena García García, Miquel Tarón, Claudio Ballestín Carcavilla, Daniel Castellanos, Hernán Cortés-Funes, Luis Paz-Ares Rodríguez
págs. 452-457
Trends in prostate cancer survival in Spain:: results from population-based cancer registries
Rafael Marcos Gragera, Diego Salmerón Martínez, Isabel Izarzugaza Lizárraga, Eva Ardanaz Aicua, Bernat-Carles Serdà, Nerea Larrañaga Larrañaga, E. San Román, Carmen Navarro Sánchez, María Dolores Chirlaque López
págs. 458-464
págs. 465-470
Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer.: A single-institution experience
Roberto Díaz Beveridge, Jorge Aparicio Urtasun, Alejandro Tormo Micó, Rafael Estevan Estevan, Josefina Artes, Alejandra Giménez Ortiz, Angel Agustín Segura Huerta, S. Roldán, Rosana Palasí Giménez, David Ramos Soler
págs. 471-480
Behaviour of breast cancer molecular subtypes through tumour progression
Carlos A. Castaneda, Eva María Andrés Esteban, Carmen Barcena, Henry L. Gómez, Hernán Cortés-Funes, Eva Ciruelos
págs. 481-485
César Gómez Raposo, Mónica Andreu, Inés Suárez García, M. Isabel Esteban, Mar Carballo, M. Sereno Moyano, José L. Vázquez Osorio, Javier Heras Aznar, Francisco Zambrana, E. Pelayo Villanueva, Miriam López Gómez, Clara García de Santiago, María Merino Salvador, Enrique Casado Sáenz
págs. 486-488
© 2001-2024 Fundación Dialnet · Todos los derechos reservados